Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

Scientists have found that antibodies stop UTI-causing E. coli by jamming or mimicking cell receptors, preventing bacterial ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

In addition, Adimab achieved 50 technical and development milestones across numerous collaborations. Since 2009, Adimab has partnered with over 140 companies to discover therapeutic drug candidates.

Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...

The patient with significant bone marrow involvement had complete bone morphological remission. In this patient in which 95% ...

Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza ...

In 2020, the world watched anxiously as scientists scrambled to develop defences against COVID-19. Faced with a new, deadly infectious disease, immunologists worked day and night to develop vaccines ...

The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...

In my short stint as a resident doctor in oncology, the overwhelming impression was one of complex and expensive treatments doing little for patient survival or quality of life. The options available ...